Lucie Křikavová
Lucie Křikavová publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Vascular Tumors and Angiosarcomas and Venous Thromboembolism Diagnosis and Management.
- World rank
- #5,967,402 of 7,710,434 ranked researchers
- Rank in Czechia
- #23,580 of 39,303
- Works
- 16
- Citations
- 52
- Citations per work
- 3.3
What does Lucie Křikavová research?
Lucie Křikavová's work is mostly in Medicine (68%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1167.5%
- Medicine1167.5%
- Everything else532.5%
- 1Oncology19% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Pathology and Forensic Medicine9% of their works
- 4Surgery9% of their works
- 5Genetics9% of their works
- 6Internal Medicine7% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Vascular Tumors and Angiosarcomas
- Venous Thromboembolism Diagnosis and Management
- Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Lymphatic System and Diseases
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Which keywords describe Lucie Křikavová's research?
The keywords of their largest research topics: Chemotherapy, Prognostic Scoring System, Clinical Practice Guidelines, Adjuvant Therapy, Angiosarcoma, Epithelioid Hemangioendothelioma, JAK2 Mutation and Myelofibrosis.
- Primary CNS Lymphoma
- Lymphangiogenesis
- Gastric Cancer
- CT Screening
- Lymphoma
- Antithrombotic Therapy
- Myelofibrosis
- Epithelioid Hemangioendothelioma
- Adjuvant Therapy
- Prognostic Scoring System
- Chemotherapy
- Clinical Practice Guidelines
- Angiosarcoma
- JAK2 Mutation
- Radiotherapy
- Classification
- Venous Thromboembolism
- Endoscopic Resection
- Lung Cancer
- Methotrexate
- VEGF-C
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy63 topics
- Prognostic Scoring System62 topics
- Clinical Practice Guidelines52 topics
- Adjuvant Therapy42 topics
- Angiosarcoma41 topic
- Epithelioid Hemangioendothelioma41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Radiotherapy42 topics
- Antithrombotic Therapy31 topic
- Classification31 topic
- Lymphoma31 topic
- Venous Thromboembolism31 topic
- CT Screening21 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Lung Cancer21 topic
- Lymphangiogenesis21 topic
- Methotrexate21 topic
- Primary CNS Lymphoma21 topic
- VEGF-C21 topic
Where does Lucie Křikavová work?
Lucie Křikavová's main affiliation in the publication record is Ocní klinika, Czechia.
How many publications and citations does Lucie Křikavová have?
OpenAlex counts 16 works and 52 citations for Lucie Křikavová, an h-index of 2, ranking #5,967,402 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lucie Křikavová. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.